<DOC>
	<DOCNO>NCT00343174</DOCNO>
	<brief_summary>Treatment acute stroke still difficult specific drug approve ( rtPA ) administer treatment start within 3 hour onset symptom . This result still small number patient treat rtPA ( &lt; 15 % best clinical care institution ) . Ancrod differently act biological drug use long time acute stroke treatment . STAT first RCT medium size show significant benefit/risk ration treatment start within 3 hour . ESTAT design closely relate STAT longer 6 hour window specifically extend inclusion/exclusion criterion avoid secondary complication possibly relate long time window .</brief_summary>
	<brief_title>Intravenous Ancrod Treatment Acute Ischemic Stroke Within 6 Hours After Onset Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Brain Infarction</mesh_term>
	<mesh_term>Ancrod</mesh_term>
	<criteria>18 year , sex Acute ischemic stroke first symptom within 6 hour begin Treatment onset symptom SSS &lt; 40 baseline ( consciousness necessary ) Clinical CT evidence brain hemorrhage hemorrhagic transformation CT evidence major sign develop infarction Coma Prior stroke within 6 week Severe hypertension ( &gt; 220 systolic &gt; 120 mm Hg diastolic ) Baseline fibrinogen &lt; 100 mg/dL Recent use thrombolytic agent Recent anticipate surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2002</verification_date>
	<keyword>stroke</keyword>
	<keyword>vascular disease</keyword>
</DOC>